| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥4839.1B | ¥5126.7B | -5.6% |
| Operating Income | ¥-1036.3B | ¥81.1B | -76.4% |
| Profit Before Tax | ¥-1018.6B | ¥108.5B | -70.0% |
| Net Income | ¥-871.7B | ¥63.1B | -74.9% |
| ROE | -15.1% | 1.0% | - |
FY2026 Q3 results show significant deterioration with revenue of 483.9B yen (YoY -5.6%), operating loss of 103.6B yen (prior year profit 8.1B yen), and net loss of 87.2B yen (prior year profit 6.3B yen). The company shifted from profitability to substantial losses across all profit levels. Despite maintaining a gross profit margin of 41.1%, selling, general and administrative expenses of 212.1B yen exceeded gross profit, driving the operating loss. Impairment losses of approximately 9.1B yen were recorded as a one-time factor. The company forecasts full-year operating loss of 100.0B yen and net loss of 85.0B yen, with Q3 results tracking in line with these projections. Cash and equivalents stood at 157.9B yen with equity ratio remaining solid at 52.4%, though operating cash flow turned negative at -14.8B yen and free cash flow deteriorated to -42.8B yen, raising concerns about earnings quality and liquidity generation.
[Profitability] ROE of -15.1% deteriorated sharply from positive territory in prior year, driven primarily by net profit margin collapsing to -18.0%. Operating margin fell to -21.4% from 6.5% in FY2024, reflecting the impact of sales decline against fixed cost burden and elevated SG&A expenses. DuPont analysis reveals asset turnover of 0.44 and financial leverage of 1.90, with the negative profit margin being the dominant factor in ROE deterioration. Gross profit margin maintained at 41.1% indicates pricing power remains intact, but cost structure misalignment is evident. [Cash Quality] Cash and equivalents of 157.9B yen provide short-term liquidity buffer. Operating cash flow to net income ratio of 0.17 falls significantly below the 0.8 quality threshold, indicating weak cash conversion of accounting earnings. Inventory position of 351.7B yen represents approximately 32.0% of total assets with days inventory outstanding of 451 days, signaling severe inventory excess and working capital inefficiency. [Investment Efficiency] Asset turnover of 0.44 reflects subdued revenue generation relative to asset base. Property, plant and equipment increased 6.9B yen YoY to 153.4B yen, indicating continued capital investment despite operating losses. Return on assets of -7.9% and return on invested capital significantly negative demonstrate poor capital efficiency in current operating environment. [Financial Health] Equity ratio of 52.4% with total equity of 577.6B yen and total assets of 1,099.8B yen maintains solid capital foundation. Debt-to-equity ratio of 0.90 indicates moderate leverage without excessive financial risk. Current ratio data shows current assets of 657.5B yen, though heavily concentrated in inventory, requiring monitoring of true liquidity position. Retained earnings decreased 104.7B yen to 408.4B yen, reflecting net loss impact and continued dividend payments.
Operating cash flow of -14.8B yen against net loss of -87.2B yen produces a cash conversion ratio of 0.17, indicating that while the accounting loss is severe, cash outflow is somewhat mitigated by non-cash charges including impairment losses. However, inventory increase of 30.5B yen and other working capital movements of -8.0B yen directly pressured operating cash flow, highlighting structural issues in inventory management and order-to-production matching. Investing cash flow of -28.1B yen was primarily driven by capital expenditures of 24.6B yen for property, plant, equipment and intangible assets, continuing investment despite operating difficulties. Financing cash flow generated 27.3B yen inflow, while dividend payments of 16.3B yen continued to be funded despite negative free cash flow of -42.8B yen, raising sustainability concerns. Free cash flow coverage of dividends and capital expenditures stands at -2.57x, meaning the company cannot self-fund these commitments from operations and is relying on cash reserves or external financing. Cash and equivalents position of 157.9B yen provides near-term buffer, but persistent negative operating cash flow would erode this cushion over time. Interest payments of 2.5B yen and lease payments of 6.0B yen further constrain cash generation. The combination of negative operating cash flow, continued capital investment, and dividend payments creates a cash flow structure requiring urgent correction through inventory reduction and operational improvement.
Ordinary loss of 101.9B yen versus operating loss of 103.6B yen shows marginal non-operating net contribution of approximately 1.7B yen, with equity method investment gains of 2.6B yen providing limited support. Non-operating income components are modest relative to the revenue base of 483.9B yen, representing less than 1% of sales. The primary earnings quality concern stems from the cash conversion weakness, with operating cash flow at -14.8B yen failing to match the net loss profile. While impairment losses of approximately 9.1B yen represent a non-recurring charge that distorts reported earnings, adjusting for this still leaves substantial operating losses driven by structural cost issues. The operating cash flow to net income ratio of 0.17 signals that even after accounting for non-cash impairments, working capital absorption particularly from inventory buildup is degrading earnings quality. Deferred tax assets increased 9.7B yen to 68.3B yen, reflecting expected future tax benefits from losses, though realizability depends on return to profitability. The fact that operating cash flow remains negative while the company recorded large non-cash impairments suggests underlying business cash generation is severely impaired beyond one-time charges. Accounts receivable turnover of 84 days and payables turnover of 77 days show relatively balanced trade credit management, but inventory turnover of 451 days represents a critical outlier requiring immediate management attention as it directly undermines cash quality.
Inventory excess risk with days inventory outstanding of 451 days versus industry median of 109 days represents severe overhang, exposing the company to demand volatility, pricing pressure, and potential additional write-downs. The inventory balance of 351.7B yen consuming 32% of total assets creates significant balance sheet risk and working capital strain. Operating cash flow sustainability risk is critical with persistent negative operating cash flow of -14.8B yen and free cash flow of -42.8B yen, while dividend payments of 16.3B yen continue despite inability to fund from operations. If operating cash flow does not recover, the current cash position of 157.9B yen could deteriorate rapidly. Profitability structure risk stems from SG&A expenses of 212.1B yen exceeding gross profit despite maintaining 41.1% gross margin, indicating fundamental cost structure misalignment that requires restructuring. Revenue decline of 5.6% against high fixed costs creates negative operating leverage, and without significant cost reduction or revenue recovery, losses may persist beyond current fiscal year guidance.
[Industry Position] (Reference - Proprietary Analysis) The company's financial metrics show significant underperformance versus manufacturing sector peers. Profitability: Operating margin of -21.4% and net profit margin of -18.0% fall far below industry medians of 8.3% and 6.3% respectively, placing the company in severe distress relative to sector norms. ROE of -15.1% versus industry median of 5.0% and ROA of -7.9% versus industry median of 3.3% indicate fundamental profitability challenges. Financial Health: Equity ratio of 52.4% compares reasonably to industry median of 63.8%, suggesting adequate capitalization despite operating losses. The company maintains lower leverage with financial leverage of 1.90 versus industry median of 1.53. Efficiency: Asset turnover of 0.44 significantly lags industry median of 0.58, reflecting weak revenue generation efficiency. Most critically, inventory turnover of 451 days is over 4x the industry median of 109 days, representing extreme working capital inefficiency. Operating working capital turnover of approximately 200+ days far exceeds industry median of 108 days. Growth: Revenue decline of -5.6% compares unfavorably to industry median growth of 2.7%, with EPS growth deeply negative versus industry median of 6%. Cash Flow: Operating cash flow to net income ratio of 0.17 falls below industry median of 1.24, and FCF yield is negative versus industry median of 2%. The company's Rule of 40 score is deeply negative versus industry median of 11%, indicating simultaneous growth and margin challenges. Overall, the company ranks in bottom quartile across most operational and financial metrics within the manufacturing sector.
(Industry: Manufacturing (98 companies), Comparison: FY2025-Q3 period, Source: Proprietary analysis)
Inventory normalization is the critical near-term priority, with days inventory outstanding of 451 days representing over 4x industry median and directly driving negative operating cash flow. Successful reduction of inventory toward industry norms could release over 200B yen in working capital, fundamentally improving cash generation and financial flexibility. The pace and execution of inventory drawdown will be the key determinant of recovery trajectory and cash flow sustainability in coming quarters. Cost structure realignment is essential for return to profitability, as current SG&A expense base of 212.1B yen cannot be supported by current revenue levels. Even with gross margin strength of 41.1%, the company requires either revenue growth of 20%+ or SG&A reduction of 40-50B yen to return to breakeven operations. Management's ability to execute structural cost reduction while protecting revenue-generating capabilities will determine medium-term viability of the business model. Dividend policy sustainability is questionable with negative free cash flow of -42.8B yen while maintaining dividend payments of 16.3B yen per quarter. The full-year forecast of 15 yen per share suggests potential dividend reduction from recent 50 yen annual rate. Investors should anticipate possible dividend cut or suspension if operating cash flow does not improve within next 2-3 quarters, as continued payments would deplete cash reserves and compromise financial stability.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.